ESC 2016: Applying Novel Therapeutics to Improve Outcomes in Patients with Pulmonary Arterial Hypertension
This CME program will cover data on current and emerging therapeutic options for treating patients with pulmonary arterial hypertension (PAH) that was presented at the European Society of Cardiology 2016 Annual Congress held in Rome, Italy…
Meeting Reporter
ESC 2016: Utilizing PCSK9 Therapies for Better Long-Term Outcomes in Dyslipidemia Patients
This CME Program will highlight information presented at the European Society of Cardiology Congress 2016 held in Rome, Italy…
Meeting Reporter, Downloadable Transcript
ACC 2016: Recent Advances to Improve Outcomes for Patients with Dyslipidemia
This Official Elsevier Medical Meeting Reporter will cover data presented at the American College of Cardiology 65th Annual Scientific Session and Expo held held in Chicago, Illinois…
Meeting Reporter, Downloadable Transcript
The Role of PCSK9 Inhibitors in the Management of Dyslipidemia in Patients with Diabetes Mellitus
This CME activity will focus on the management of dyslipidemia in patients with diabetes mellitus and the role of PCSK9 inhibitors in this therapeutic area.
Applying PCSK9 Therapeutics to the Right Dyslipidemia Patients at the Right Time
Coronary Heart Disease (CHD) remains a significant cause of mortality, accounting for 1 out of 4 deaths in the United States, despite greater control of risk factors and improved treatments…
Webcast, Downloadable Transcript